Search
for
Sort by
Research 31–60 of 273
- Hair Loss in Psychopharmacology
- 392 Hair loss after drug reaction with eosinophilia and systemic symptoms: A multicentric retrospective study
- Psychotropic Medication and Drug-Related Alopecia
- Alopecia and Mood Stabilizer Therapy
- Concurrence of Palmoplantar Psoriasiform Eruptions and Hair Loss during Carbamazepine Treatment
- Drug-induced changes in hair growth
- Drug-Induced Hair Loss and Hair Growth
- Drug-Induced Hair Disorders
- An overview of management of drug-induced hair and nail disorders
- Drug-induced male infertility: a real-world study using FAERS and EudraVigilance databases
- Real-world pharmacovigilance insights into drug-induced risk of alopecia
- Chemically Induced Hair Loss/Alopecia
- An Update on Drug-Induced Pigmentation
- 5alpha-reductase inhibitors dampen L-DOPA-induced dyskinesia via normalization of dopamine D1-receptor signaling pathway and D1-D3 receptor interaction
- Valproate-acid-induced cutaneous leukocytoclastic vasculitis.
- [Drug induced alopecia].
- Telogen Effluvium Caused by Magnesium Valproate and Lamotrigine
- Sodium Valproate-Induced Hyperpigmentation
- [Visual field defect in a patient given sodium valporate then carbamazepine: possible effect of aminotransferase inhibition].
- Pellagroid dermatitis during a ketogenic diet and anti-epileptic therapy.
- Biotin
- Serum drug level-related sodium valproate-induced hair loss
- Serum Biotinidase Activity in Children Treated With Valproic Acid and Carbamazepine
- Diseases of the skin. Drug ill effects on the skin.
- Finasteride Induced Cerebral Venous Thrombosis
- Cyclosporine-induced alopecia:a case report, FDA adverse event reporting system analysis and literature assessment
- Valproate-induced thrombocytopenia
- Cutaneous lupus erythematosus. Diagnostic and therapeutic recommendations of the Polish Dermatological Society
- Psoriasis
- Obesity, polycystic ovarian syndrome and thyroid dysfunction in women with epilepsy